Advertisement

Topics

Companies Related to "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" [Most Relevant Company Matches] - Page: 2 RSS

23:59 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" found in our extensive corporate database of over 50,000 company records.

Showing "Study Assess Safety Dose Conversion Dose Individualization Duragesic" Companies 26–50 of 2,200+

Relevant

Radimetrics

Radimetrics provides radiation dose monitoring and management software to hospitals and imaging centers. Radimetrics’ flagship product, eXposure™ is a single-system solution for tracking full body, organ-specific and cumulative radiation exposure across all imaging modalities. It provides crucial patient size-adjusted information to improve decis...


Kubtec

Kubtec, a registered trademark of KUB Technologies, Inc., develops and manufactures digital X-ray systems for specimen radiography, low-dose neonatal imaging, scientific research, forensic analysis, non-destructive testing, irradiation and more. With nearly 10 years of industry firsts, Kubtec is reigniting the field of radiography with its introduction of ...

TOPICA Pharmaceuticals, Inc.

TOPICA Pharmaceuticals, Inc. is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, or fungal infections of the nail. The company is focused on conducting the Phase 2b/3 SOLUTION Study, a robust dose finding and proof of efficacy trial with luliconazole in onychomycosis with...


Green Oak Diagnostics

Green Oak Diagnostics is a fully ACR-accredited diagnostic imaging facility, offering comprehensive High Field MRI, Open MRI, and Low Dose CT services. Committed to exceeding national quality standards and safety guidelines, it is an active participant in the American College of Radiologists’ “Image Wisely” and “Image Gently” campaigns, s...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...

Azaya Therapeutics Inc.

Azaya Therapeutics, Inc. is an oncology company focused on developing more effective cancer treatments through its novel nanotechnology platform. Azaya’s patented Protein Stabilized Liposomes™ (PSL) platform allows for high-dose delivery of potent cytotoxics with potentially lower side effects. ATI-1123, is a novel liposomal encapsulation of Doce...

IH Systems

Founded in 2006, Intelligent Hospital Systems (IH Systems) is a medical device company focused on the design and development of automated solutions for the hospital environment. Based in Winnipeg, Manitoba, IH Systems manufactures RIVA, a fully-automated IV compounding system that prepares medications for syringes and IV bags in an aseptic environment. Usi...

MAJOR PHARMACEUTICALS

MAJOR Pharmaceuticals is one of the leading suppliers of Rx, Unit Dose and OTCs in the Managed Care (non-retail) market.

Horizon Pharma, Inc.

Horizon Pharma, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and chronic inflammation. Horizon's product portfolio includes innovative therapies in early- and late-stage development that are designed to improve the efficacy, safety and quality of life for patients with chronic pain and inflammati...

PediaCare

Dr. David Hill, father, pediatrician and author of “Dad to Dad: Parenting like a Pro,” partnered with PediaCare® to introduce a new single dose children’s medicine product. (Photo: Business Wire)

Anabolic Laboratories, Inc

Anabolic Laboratories, Inc. is a fully licensed, FDA registered pharmaceutical manufacturing facility specializing in solid dose Rx and OTC drugs, as well as custom dietary supplement formulations.

Conversion Whale

Founded in 2014, Conversion Whale is a rapidly-growing marketing firm that focuses solely on partnering with dental practices. Conversion Whale’s dedicated and knowledgeable staff specializes in turning existing websites into profitable marketing engines and promises its clients a minimum of 50 new leads a month. The company currently partners with mo...

Spaulding Clinical

Spaulding Clinical (www.spauldingclinical.com) is a Phase 1 Clinical Pharmacology Research Unit and Electrocardiography Core Lab located in West Bend, Wisconsin offering a full range of services. The company has extensive experience conducting TQT studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, a...

RheoGene Inc

RheoGene is developing the RheoSwitch® Therapeutic System (RTS) for cell and gene therapy. RTS delivers therapeutic gene products in the patient to the right place, at the right time, and at the right dose. Despite advances in the understanding of the genetic and molecular basis of disease, there are no approved gene therapy products on the market today, in part because of the unmet need for effi...

Aplicare, Inc

Founded in 1983 and headquartered in Meriden, CT, Aplicare is a market leader in the formulation, production and packaging of topical antiseptic and personal care products for use in today's professional health care setting. Just recently, we expanded our offering to include sterile procedural kits and trays including the first innovation in procedural kit design in over 30 years. Click here for ...

Berzelius Clinical Research Center

Berzelius Clinical Research Center AB (BCRC) is a unique Site Management Organisation specialised in clinical conduct of Phase 0/I/II studies and the ideal partner for Contract Research Organisations (CRO) and pharmaceutical companies. BCRC has a hospital based well-equipped clinical pharmacology unit. Having a fully trained critical care staff enables easy setup of invasive techniques and procedu...

Entropin

Entropin, Inc. (NASDAQ: ETOP) is a specialty pharmaceutical development company focused on commercializing Esterom®, a revolutionary new topical drug with the potential to replace other current therapeutics for treating impaired physical function resulting from painful soft tissue injuries and diseases -- such as tendonitis, bursitis and lower back sprain. The Esterom® market is currently served...

VeriTeQ Acquisition Corporation

VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosi...

Delcath Systems, Inc.

Delcath Systems, Inc. is a development stage, specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of pri...

Lumitron Technologies, Inc.

Based in Irvine, California, Lumitron Technology Inc. was established to develop and commercialize unique X‐ray systems that enable revolutionary new capabilities for high‐fidelity imaging, ultra‐low dose imaging and hyper‐precision radiotherapy.

Intelligent Hospital Systems Ltd.

Founded in 2006, Intelligent Hospital Systems (IH Systems) is a medical device company focused on the design and development of automated solutions for the hospital environment. Based in Winnipeg, Manitoba, IH Systems manufactures the Robotic IV Automation (RIVA), an advanced-technology robotic system that prepares IV syringes and bags safely and accuratel...

Ziarco

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting inflammatory and allergic diseases. The company’s product pipeline includes ZPL-3893787, an H4 receptor antagonist that has completed a Phase 1 multiple ascending dose study. A second clinical-stage, programme targets inflammatory disorders by inhibiting cyto...

TransOral Pharmaceuticals, Inc

TransOral Pharmaceuticals, Inc., is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. The Company's initial proprietary technology is being employed to accelerate efficacy and reduce drug dose in the development of therapeutics for the treatment of migraine and insomnia.

Digital Angel Corporation

Digital Angel, through its VeriTeQ wholly-owned subsidiary, develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in v...

CytoSen Therapeutics, Inc.

CytoSen is a private biopharmaceutical company on the front line of advancing clinical development of next generation NK cells with the first scalable, therapeutic platform for high dose, cancer-killing NK cells calibrated to each cancer target while reinforcing immune defenses.


More From BioPortfolio on "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks